|
Luengo-Gil G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, Chaves-Benito A, Garcia-Martinez E, Garcia-Garre E, Vicente V, Ayala de la Peña F. Angiogenic role of miR-20a in breast cancer. PLoS One. 2018 Apr 4;13(4):e0194638. doi: 10.1371/journal.pone.0194638. eCollection 2018. PubMed PMID: 29617404; PubMed Central PMCID: PMC5884522.
AÑO: 2018; IF: 2.776
|
29617404
|
Luengo-Gil G, Garcia-Martinez E, Chaves-Benito A, Conesa-Zamora P, Navarro-Manzano E, Gonzalez-Billalabeitia E, Garcia-Garre E, Martinez-Carrasco A, Vicente V, Ayala de la Pena F. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy. Cell Oncol (Dordr). 2019 Oct;42(5):627-644. doi: 10.1007/s13402-019-00450-2. Epub 2019 May 21. PubMed PMID: 31115881.
AÑO: 2019; IF: 5.304
|
|
Ivars Rubio A, Yufera JC, de la Morena P, Fernandez Sanchez A, Navarro Manzano E, Garcia Garre E, Garcia Martinez E, Marin Zafra G, Sanchez Canovas M, Garcia Torralba E, Ayala de la Pena F. Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables. Sci Rep. 2019 Nov 18;9(1):16979. doi: 10.1038/s41598-019-53606-3. PubMed PMID: 31740715; PubMed Central PMCID: PMC6861311.
AÑO: 2019; IF: 3.998
|
|
Vicente Conesa MA, Zafra Poves M, Carmona-Bayonas A, Ballester Navarro I, de la Morena Barrio P, Ivars Rubio A, Montenegro Luis S, Garcia Garre E, Vicente V, Ayala de la Pena F. A prognostic model to identify short survival expectancy of medical oncology patients at the time of hospital discharge. ESMO Open. 2022 Feb;7(1):100384. doi: 10.1016/j.esmoop.2022.100384. Epub 2022 Feb 7. PubMed PMID: 35144121; PubMed Central PMCID: PMC8844687.
AÑO: 2022; IF: 6.883
|
|
Navarro-Manzano E, Luengo-Gil G, Gonzalez-Conejero R, Garcia-Garre E, Garcia-Martinez E, Garcia-Torralba E, Chaves-Benito A, Vicente V, Ayala de la Pena F. Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer. Cancers (Basel). 2022 May 12;14(10):2390. doi: 10.3390/cancers14102390. PubMed PMID: 35625994; PubMed Central PMCID: PMC9139340.
AÑO: 2022; IF: 6.575
|